ARS PHARMACEUTICALS INC (SPRY) Institutional Ownership Changes & 13F Activity
ARS PHARMACEUTICALS INC (SPRY). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ra Capital Management, L.P., Orbimed Advisors Llc, Deerfield Management Company, L.P., Millennium Management Llc, and Citadel Advisors Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Neuberger Berman Group Llc | Sell | -324,877 | -100.0% | 0 | $0.00 | Q4 2025 | Oct 27, 2026 |
| Cygnus Capital Advisors, Llc | Buy | +10,556 | — | 10,556 | $123.00K | Q4 2025 | May 12, 2026 |
| Strategic Wealth Partners, Ltd. | Buy | +20 | — | 20 | $233.00 | Q4 2025 | May 12, 2026 |
| Raymond James Financial Inc | Buy | +566,056 | — | 566,056 | $6.59M | Q4 2025 | Feb 18, 2026 |
| Creek Drive Management Group Llc | Buy | +295,863 | — | 295,863 | $3.45M | Q4 2025 | Feb 18, 2026 |
| Coastal Bridge Advisors, Llc | Buy | +53,830 | — | 53,830 | $627.12K | Q4 2025 | Feb 18, 2026 |
| Ra Capital Management, L.P. | Buy | +10,860,977 | — | 10,860,977 | $126.53M | Q4 2025 | Feb 17, 2026 |
| Orbimed Advisors Llc | Buy | +8,288,510 | — | 8,288,510 | $96.56M | Q4 2025 | Feb 17, 2026 |
| Deerfield Management Company, L.P. | Buy | +7,503,812 | — | 7,503,812 | $87.42M | Q4 2025 | Feb 17, 2026 |
| Millennium Management Llc | Buy | +3,168,406 | — | 3,168,406 | $36.91M | Q4 2025 | Feb 17, 2026 |
| Citadel Advisors Llc | Buy | +1,954,472 | — | 1,954,472 | $22.77M | Q4 2025 | Feb 17, 2026 |
| Casdin Capital, Llc | Buy | +1,600,000 | — | 1,600,000 | $18.64M | Q4 2025 | Feb 17, 2026 |
| Southpoint Capital Advisors Lp | Buy | +1,500,000 | — | 1,500,000 | $17.48M | Q4 2025 | Feb 17, 2026 |
| Bamco Inc | Buy | +1,268,532 | — | 1,268,532 | $14.78M | Q4 2025 | Feb 17, 2026 |
| Fil Ltd | Buy | +810,073 | — | 810,073 | $9.44M | Q4 2025 | Feb 17, 2026 |
| Nextech Invest, Ltd. | Buy | +660,703 | — | 660,703 | $7.70M | Q4 2025 | Feb 17, 2026 |
| Third Point | Buy | +556,237 | — | 556,237 | $6.48M | Q4 2025 | Feb 17, 2026 |
| Northern Trust Corp | Buy | +521,009 | — | 521,009 | $6.07M | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +482,084 | — | 482,084 | $5.62M | Q4 2025 | Feb 17, 2026 |
| Fmr Llc | Buy | +398,959 | — | 398,959 | $4.65M | Q4 2025 | Feb 17, 2026 |
| Adar1 Capital Management, Llc | Buy | +369,569 | — | 369,569 | $4.31M | Q4 2025 | Feb 17, 2026 |
| Eversept Partners, Lp | Buy | +251,593 | — | 251,593 | $2.93M | Q4 2025 | Feb 17, 2026 |
| Boothbay Fund Management, Llc | Buy | +201,474 | — | 201,474 | $2.35M | Q4 2025 | Feb 17, 2026 |
| Dafna Capital Management Llc | Buy | +190,065 | — | 190,065 | $2.21M | Q4 2025 | Feb 17, 2026 |
| Woodline Partners Lp | Buy | +150,936 | — | 150,936 | $1.76M | Q4 2025 | Feb 17, 2026 |
| Trexquant Investment Lp | Buy | +150,100 | — | 150,100 | $1.75M | Q4 2025 | Feb 17, 2026 |
| Alliancebernstein L.P. | Buy | +60,120 | — | 60,120 | $700.40K | Q4 2025 | Feb 17, 2026 |
| California State Teachers Retirement System | Buy | +54,098 | — | 54,098 | $630.24K | Q4 2025 | Feb 17, 2026 |
| Quantinno Capital Management Lp | Buy | +53,113 | — | 53,113 | $618.77K | Q4 2025 | Feb 17, 2026 |
| Xtx Topco Ltd | Buy | +37,201 | — | 37,201 | $433.39K | Q4 2025 | Feb 17, 2026 |
Frequently asked questions about SPRY activity
Which institutional owners are buying SPRY?
Institutional owners buying SPRY include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in SPRY activity?
"Buy" means an investor increased their reported position in SPRY compared to the prior reporting period. This reflects growing exposure to ARS PHARMACEUTICALS INC (SPRY) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in SPRY increasing?
Institutional interest in SPRY can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related SPRY Institutional Insights
- SPRY Overview
- SPRY 13F Institutional Holders
- SPRY Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- SPRY Insider Trading & SEC Form 4 Activity
- SPRY Articles
- Top Institutional Investor Stock Rankings